Comparison of Insulin Glargine Against Insulin Aspart Infused Under the Skin in Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
2006-01-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The objective of the study is to investigate the effect
and safety of continously basal delivered insulin aspart given by a pump versus once daily
injection of insulin glargine.